Figure 5
From: Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule
Histogram representation of the decrement in the amplitude of the compound muscle action potential. CMAP was compared at 4 months with respect to values at 3 months of age in SOD1G93A mice, untreated and treated with naked DNA encoding for BDNF, TTC or BDNF-TTC. For each group, the left bar corresponds to the gastrocnemius muscle and the right bar to the plantar muscle (n = 7 mice per group).